459 related articles for article (PubMed ID: 18574040)
1. Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura.
Sadler JE
Blood; 2008 Jul; 112(1):11-8. PubMed ID: 18574040
[TBL] [Abstract][Full Text] [Related]
2. Thrombotic thrombocytopenic purpura: a moving target.
Sadler JE
Hematology Am Soc Hematol Educ Program; 2006; ():415-20. PubMed ID: 17124092
[TBL] [Abstract][Full Text] [Related]
3. [Thrombotic Thrombocytopenic Purpura --Pathophysiology and Assays of ADAMTS13 Activity].
Kato S; Fujimura Y
Rinsho Byori; 2015 Oct; 63(10):1228-36. PubMed ID: 26897861
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of microvascular thrombosis in thrombotic thrombocytopenic purpura.
Tsai HM
Kidney Int Suppl; 2009 Feb; (112):S11-4. PubMed ID: 19180123
[TBL] [Abstract][Full Text] [Related]
5. Two cases of refractory thrombotic thrombocytopenic purpura associated with collagen vascular disease were significantly improved by rituximab treatment.
Kameda T; Dobashi H; Kittaka K; Susaki K; Yamaoka G; Arai K; Tokuda M; Ishida T
Clin Rheumatol; 2007 Dec; 26(12):2159-2162. PubMed ID: 17562094
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in thrombotic thrombocytopenic purpura.
Sadler JE; Moake JL; Miyata T; George JN
Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695
[TBL] [Abstract][Full Text] [Related]
7. [Thrombotic-thrombocytopenic purpura].
Hellmann M; Hallek M; Scharrer I
Internist (Berl); 2010 Sep; 51(9):1136, 1138-44. PubMed ID: 20689903
[TBL] [Abstract][Full Text] [Related]
8. Current insight into thrombotic thrombocytopenic purpura.
Verbeke L; Delforge M; Dierickx D
Blood Coagul Fibrinolysis; 2010 Jan; 21(1):3-10. PubMed ID: 19851089
[TBL] [Abstract][Full Text] [Related]
9. Rituximab and intermediate-purity plasma-derived factor VIII concentrate (Koate®) as adjuncts to therapeutic plasma exchange for thrombotic thrombocytopenic purpura in patients with an ADAMTS13 inhibitor.
Pandey S; Nakagawa M; Rosenbaum ER; Arnaoutakis K; Hutchins LF; Makhoul I; Milojkovic N; Cottler-Fox M
J Clin Apher; 2015 Feb; 30(1):50-4. PubMed ID: 25042026
[TBL] [Abstract][Full Text] [Related]
10. Current management and therapeutical perspectives in thrombotic thrombocytopenic purpura.
Coppo P; Veyradier A
Presse Med; 2012 Mar; 41(3 Pt 2):e163-76. PubMed ID: 22265954
[TBL] [Abstract][Full Text] [Related]
11. Thrombotic thrombocytopenic purpura: a thrombotic disorder caused by ADAMTS13 deficiency.
Tsai HM
Hematol Oncol Clin North Am; 2007 Aug; 21(4):609-32, v. PubMed ID: 17666281
[TBL] [Abstract][Full Text] [Related]
12. [Recent therapeutic strategy for thrombotic thrombocytopenic purpura].
Fujimura Y; Matsumoto M; Isonishi A; Yagi H; Kokame K; Miyata T
Rinsho Ketsueki; 2014 Jan; 55(1):93-104. PubMed ID: 24492042
[No Abstract] [Full Text] [Related]
13. Thrombotic thrombocytopenic purpura-what is new?
Shah N; Sarode R
J Clin Apher; 2013 Feb; 28(1):30-5. PubMed ID: 23420593
[TBL] [Abstract][Full Text] [Related]
14. Rituximab for treatment of refractory/relapsing thrombotic thrombocytopenic purpura (TTP).
Ahmad A; Aggarwal A; Sharma D; Dave HP; Kinsella V; Rick ME; Schechter GP
Am J Hematol; 2004 Oct; 77(2):171-6. PubMed ID: 15389904
[TBL] [Abstract][Full Text] [Related]
15. Remission of chronic thrombotic thrombocytopenic purpura after treatment with cyclophosphamide and rituximab.
Zheng X; Pallera AM; Goodnough LT; Sadler JE; Blinder MA
Ann Intern Med; 2003 Jan; 138(2):105-8. PubMed ID: 12529092
[TBL] [Abstract][Full Text] [Related]
16. A Canadian phase II study evaluating the efficacy of rituximab in the management of patients with relapsed/refractory thrombotic thrombocytopenic purpura.
Foley SR; Webert K; Arnold DM; Rock GA; Clark WF; Barth D; Sutton DM;
Kidney Int Suppl; 2009 Feb; (112):S55-8. PubMed ID: 19180138
[TBL] [Abstract][Full Text] [Related]
17. Pathophysiology of thrombotic thrombocytopenic purpura.
Tsai HM
Int J Hematol; 2010 Jan; 91(1):1-19. PubMed ID: 20058209
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy for thrombotic thrombocytopenic purpura.
Cataland SR; Wu HM
Curr Opin Hematol; 2005 Sep; 12(5):359-63. PubMed ID: 16093780
[TBL] [Abstract][Full Text] [Related]
19. Efficiency of curative and prophylactic treatment with rituximab in ADAMTS13-deficient thrombotic thrombocytopenic purpura: a study of 11 cases.
Fakhouri F; Vernant JP; Veyradier A; Wolf M; Kaplanski G; Binaut R; Rieger M; Scheiflinger F; Poullin P; Deroure B; Delarue R; Lesavre P; Vanhille P; Hermine O; Remuzzi G; Grünfeld JP
Blood; 2005 Sep; 106(6):1932-7. PubMed ID: 15933059
[TBL] [Abstract][Full Text] [Related]
20. Paradigm shift of childhood thrombotic thrombocytopenic purpura with severe ADAMTS13 deficiency.
Yagi H; Matsumoto M; Fujimura Y
Presse Med; 2012 Mar; 41(3 Pt 2):e137-55. PubMed ID: 22264931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
